Back to Journals » OncoTargets and Therapy » Volume 9

Usefulness of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in hormone-receptor-negative breast cancer

Authors Liu C, Huang Z, Wang Q, Sun B, Ding L, Meng X, Wu S

Received 7 February 2016

Accepted for publication 1 June 2016

Published 27 July 2016 Volume 2016:9 Pages 4653—4660

DOI https://doi.org/10.2147/OTT.S106017

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Manfred Beleut

Peer reviewer comments 4

Editor who approved publication: Professor Min Li


Chao Liu,1,2 Zhou Huang,1 Qiusheng Wang,1 Bing Sun,1 Lijuan Ding,1 Xiangying Meng,1 Shikai Wu1,2

1Department of Radiation Oncology, Affiliated Hospital of Academy of Military Medical Sciences, 2Department of Radiation Oncology, 307 Hospital of PLA, 307 Clinical College, Anhui Medical University, Beijing, People’s Republic of China

Purpose: We aimed to investigate the relationship between pretreatment neutrophil-to-lymphocyte ratio (NLR)/platelet-to-lymphocyte ratio (PLR) and the estimation of hormone-receptor-negative (HR-) breast cancer patients’ survival in a Chinese cohort.
Patients and methods: Of 434 consecutive HR- nonmetastatic breast cancer patients treated between 2004 and 2010 in the Affiliated Hospital of Academy of Military Medical Sciences, 318 eligible cases with complete data were included in the present study. Kaplan–Meier analysis was performed to determine the overall survival (OS) and disease-free survival (DFS). Univariate and multivariate Cox proportional hazards models were used to test the usefulness of NLR and PLR.
Results: Univariate analysis indicated that both elevated NLR and PLR (both P<0.001) were associated with poor OS. The utility of NLR remained in the multivariate analysis (P<0.001), but not PLR (P=0.104). The analysis results for DFS were almost the same as OS. Subgroup analysis revealed a significant association between increased NLR and PLR (P<0.001 and P=0.011) and poor survival in triple-negative breast cancer. However, for human epidermal growth factor receptor 2-positive breast cancer, only NLR was significantly associated with OS in the multivariate analysis (P=0.001).
Conclusion: The present study indicates that both increased NLR and PLR are associated with poor survival in HR- breast cancer patients. Meanwhile, NLR is independently correlated with OS and DFS, but PLR is not.

Keywords: inflammatory markers, breast cancer, survival

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]